| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beone Medicines Ltd. (ONC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 57 sells. ONC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.58M | $1.24B | - | |
| Pres | 1.45M | $392.10M | - | |
| VP | 97.0K | $26.21M | - | |
| CEO | 3.3K | $882.9K | - | |
| Dir | 2.6K | $709.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Oyler John59 | Chief Executive Officer | Sale+OE | 58,590 | $249.13 | $14,596,247.17 | -16.6% | +4.0% | +21.9% | |
| Mar 6, 2025 | Oyler John59 | Chief Executive Officer | Sale+OE | 40,109 | $259.15 | $10,394,328.73 | -30.9% | +0.5% | +17.2% | |
| Mar 5, 2025 | Wu Xiaobin54 | President, COO &Gm China | Sale+OE | 51,921 | $261.59 | $13,581,904.64 | -47.7% | -4.0% | +11.7% | |
| Mar 4, 2025 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sell | 8,146 | $254.58 | $2,073,826.31 | -25.9% | -4.4% | +16.2% | |
| Mar 3, 2025 | Oyler John59 | Chief Executive Officer | Sale+OE | 101,000 | $244.30 | $24,674,638.28 | -17.4% | +0.2% | +21.0% | |
| Feb 28, 2025 | Baker Bros. Advisors LP59 | Director | Sell | 732,827 | $260.00 | $190,535,020.00 | -7.7% | -9.2% | +16.5% | |
| Feb 28, 2025 | Wu Xiaobin54 | President, COO &Gm China | Sell | 0 | $0.00 | - | New | -9.2% | +16.5% | |
| Feb 27, 2025 | Lee Chan Henry47 | SVP, General Counsel | Sell | 1,205 | $275.00 | $331,375.00 | -100% | -13.6% | +13.8% | |
| Feb 21, 2025 | Wang Lai51 | Global Head Of R&D | Sell | 5,000 | $257.23 | $1,286,174.03 | -29.5% | -6.5% | +41.8% | |
| Feb 21, 2025 | Lee Chan Henry47 | SVP, General Counsel | Sell | 1,202 | $258.04 | $310,169.72 | -60.1% | -6.5% | +41.8% |